Literature DB >> 25722208

BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas.

Francisco J Valiente-Soriano1, Francisco M Nadal-Nicolás1, Manuel Salinas-Navarro1, Manuel Jiménez-López1, Jose M Bernal-Garro1, Maria P Villegas-Pérez1, Marta Agudo-Barriuso1, Manuel Vidal-Sanz1.   

Abstract

PURPOSE: To study the responses of the general population of retinal ganglion cells (Brn3a(+)RGCs) versus the intrinsically photosensitive RGCs (melanopsin-expressing RGCs [m(+)RGCs]) to ocular hypertension (OHT), the effects of brain-derived neurotrophic factor (BDNF) on the survival of axonally intact and axonally nonintact RGCs, and the correlation of vascular integrity with sectorial RGC loss.
METHODS: In Sprague-Dawley rats, 5 μg BDNF or vehicle was intravitreally injected into the left eye followed by laser photocoagulation of the limbal tissues. To identify RGCs with an active retrograde axonal transport, Fluorogold was applied to both superior colliculi 1 week before euthanasia (FG(+)RGCs). Retinas were dissected 12 or 15 days after lasering and immunoreacted against Brn3a (to identify all RGCs except m(+)RGCs), melanopsin, or RECA1 (inner retinal vasculature).
RESULTS: Ocular hypertension resulted at 12 to 15 days in sectorial loss of FG(+)RGCs (78%-84%, respectively) while Brn3a(+)RGCs were significantly greater, indicating that a substantial proportion (approximately 21%-26%) of RGCs with their retrograde axonal transport impaired survive in the retina. Brain-derived neurotrophic factor increased the survival of Brn3a(+)RGCs to 81% to 67% at 12 to 15 days, respectively. The inner retinal vasculature showed no abnormalities that could account for the sectorial loss of RGCs. At 12 to 15 days, m(+)RGCs decreased to approximately 50% to 51%, but this loss was diffuse across the retina and was not prevented by BDNF.
CONCLUSIONS: The responses of m(+)RGCs against OHT-induced retinal degeneration and neuroprotection differ from those of Brn3a(+)RGCs; while OHT induces similar loss of Brn3a(+)RGCs and m(+)RGCs, Brn3a(+)RGCs are lost in sectors and can be rescued with BDNF, but m(+)RGCs do not respond to BDNF and their loss is diffuse. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  BDNF neuroprotection; Brn3a; Fluorogold; adult albino rats; axonal transport; experimental glaucoma; intrinsically photosensitive RGCs; laser-induced ocular hypertension; melanopsin; melanopsin retinal ganglion cells; ocular hypertension; spatial distribution

Mesh:

Substances:

Year:  2015        PMID: 25722208     DOI: 10.1167/iovs.15-16454

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Relationship between Sigma-1 receptor and BDNF in the visual system.

Authors:  Barbara A Mysona; Jing Zhao; Sylvia Smith; Kathryn E Bollinger
Journal:  Exp Eye Res       Date:  2017-10-12       Impact factor: 3.467

Review 2.  Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases.

Authors:  Ningzhi Zhang; Xuejun He; Yiqiao Xing; Ning Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 3.117

Review 3.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

4.  Role of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma.

Authors:  B A Mysona; J Zhao; K E Bollinger
Journal:  Expert Rev Ophthalmol       Date:  2016-11-23

5.  Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats.

Authors:  María F González Fleitas; Julián Devouassoux; Marcos L Aranda; Hernán H Dieguez; Juan S Calanni; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Mol Neurobiol       Date:  2021-03-31       Impact factor: 5.590

6.  Retinal Molecular Changes Are Associated with Neuroinflammation and Loss of RGCs in an Experimental Model of Glaucoma.

Authors:  José A Fernández-Albarral; Juan J Salazar; Rosa de Hoz; Eva M Marco; Beatriz Martín-Sánchez; Elena Flores-Salguero; Elena Salobrar-García; Inés López-Cuenca; Vicente Barrios-Sabador; Marcelino Avilés-Trigueros; Francisco J Valiente-Soriano; Juan A Miralles de Imperial-Ollero; Manuel Vidal-Sanz; Alberto Triviño; José M Ramírez; Meritxell López-Gallardo; Ana I Ramírez
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Identifying specific RGC types may shed light on their idiosyncratic responses to neuroprotection.

Authors:  Manuel Vidal-Sanz; Francisco M Nadal-Nicolás; Francisco J Valiente-Soriano; Marta Agudo-Barriuso; Maria P Villegas-Pérez
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

8.  Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB.

Authors:  Eline Dekeyster; Emiel Geeraerts; Tom Buyens; Chris Van den Haute; Veerle Baekelandt; Lies De Groef; Manuel Salinas-Navarro; Lieve Moons
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury.

Authors:  Francisco M Nadal-Nicolás; Caridad Galindo-Romero; Francisco J Valiente-Soriano; María Barberà-Cremades; Carlos deTorre-Minguela; Manuel Salinas-Navarro; Pablo Pelegrín; Marta Agudo-Barriuso
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

10.  Investigations into Hypoxia and Oxidative Stress at the Optic Nerve Head in a Rat Model of Glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Front Neurosci       Date:  2017-08-24       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.